Beauty Health (NASDAQ:SKIN) Coverage Initiated by Analysts at TD Cowen

TD Cowen assumed coverage on shares of Beauty Health (NASDAQ:SKIN) in a report published on Friday morning,Zacks reports. The brokerage issued a hold rating on the stock.

A number of other research analysts also recently issued reports on SKIN. Zacks Research downgraded shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. Jefferies Financial Group reaffirmed a “hold” rating and set a $11.00 target price (up from $0.85) on shares of Beauty Health in a research report on Monday, October 19th. Stifel Nicolaus set a $10.00 price target on shares of Beauty Health in a report on Thursday, October 15th. Canaccord Genuity Group set a $11.00 price objective on Beauty Health and gave the stock a “hold” rating in a research note on Thursday, October 22nd. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Beauty Health in a research note on Wednesday, October 21st. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Beauty Health currently has an average rating of “Hold” and a consensus price target of $18.00.

Beauty Health Price Performance

Shares of SKIN stock opened at $9.94 on Friday. Beauty Health has a 1-year low of $9.68 and a 1-year high of $34.80. The stock’s 50-day moving average is $12.48 and its 200 day moving average is $16.85. The company has a market cap of $64.68 million, a P/E ratio of -2.26 and a beta of 1.05. The company has a debt-to-equity ratio of 4.36, a current ratio of 1.76 and a quick ratio of 1.48.

Beauty Health (NASDAQ:SKIN) last posted its earnings results on Thursday, August 6th. The company reported ($0.40) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.50) by $0.10. The company had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. Beauty Health had a negative return on equity of 47.83% and a negative net margin of 9.79%. Research analysts predict that Beauty Health will post -3.18 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Beauty Health

A hedge fund recently raised its stake in Beauty Health stock. Bank of America Corp DE lifted its stake in The Beauty Health Company (NASDAQ:SKIN) by 19.2% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 106,242 shares of the company’s stock after buying an additional 17,088 shares during the quarter. Bank of America Corp DE owned approximately 0.08% of Beauty Health worth $95,000 as of its most recent SEC filing. 93.26% of the stock is currently owned by institutional investors.

About Beauty Health

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.